Flunisolide HFA in Children With Small Airway Disease
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how two doses of Flunisolide HFA (an FDA approved inhaled
medication to treat asthma) affect the small airways in children with asthma.